ARK Genomic Revolution ETF
ARKG
ARKG
235 hedge funds and large institutions have $574M invested in ARK Genomic Revolution ETF in 2024 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 38 increasing their positions, 88 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
235
Holders Change
-2
Holders Change %
-0.84%
% of All Funds
3.13%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
46
Increased
38
Reduced
88
Closed
40
Calls
$90.4M
Puts
$70.7M
Net Calls
+$19.7M
Net Calls Change
+$5.06M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$82M |
| 2 |
2
Goldman Sachs
New York
|
$85.4M |
| 3 |
3
Two Sigma Investments
New York
|
$22.6M |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$5.95M |
| 5 |
5
Jane Street
New York
|
$7.95M |
